BTIG Maintains Buy on CareDx, Raises Price Target to $74

Benzinga Newsdesk www.benzinga.com Positive 66.9%

Neg 0% Neu 0% Pos 66.9%

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $60 to $74.

Comments

No comments yet. Be the first!